Baystreet Staff - Thursday, September 24, 2026 Ventripoint Diagnostics Ltd 10:31 AM EST - Ventripoint Diagnostics Ltd : Announced the completion of its annual quality and regulatory audits covering the Medical Device Single Audit Program, ISO 13485:2016 Quality Management System and the European Union Medical Device Regulation (MDR 2017/745). Ventripoint Diagnostics Ltd shares V.VPT are trading unchanged at $0.09. Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=VPT%3ACC&qmodStoryID=6583268573203323